Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia

Haleon and A*STAR IHDP announced the launch of the ISMOS clinical study to evaluate Centrum's impact on metabolic health in midlife Asian women. The study addresses the underrepresentation of this demographic in global research and builds on prior data linking higher vitamin levels to better health markers.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.